(Q32035364)

English

Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

0 references

1 reference

based on heuristic

inferred from title

hemodialysis patient

1 reference

based on heuristic

inferred from title

author name string

Movilli E

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Cancarini GC

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Zani R

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Camerini C

4

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Sandrini M

5

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Maiorca R

6

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

111-114

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

Optimal haemoglobin during treatment with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

Poor response to erythropoietin

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

R-HuEPO hyporesponsiveness--who and why?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

A randomized controlled study of iron supplementation in patients treated with erythropoietin

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

Identification of Spermine as an Inhibitor of Erythropoiesis in Patients with Chronic Renal Failure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

Evidence-based recommendations for the clinical use of recombinant human erythropoietin.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

The dose of hemodialysis and patient mortality

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

Dialysis dose, membrane type, and anemia control

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

NKF-DOQI clinical practice guidelines for hemodialysis adequacy. National Kidney Foundation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.1.111

21 January 2018

Identifiers

10.1093/NDT/16.1.111

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32035364&oldid=2165232545"